会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Amino- or guanidino-phenylpropionic acid derivatives
    • 氨基或胍基 - 苯基丙酸衍生物
    • US4182897A
    • 1980-01-08
    • US917232
    • 1978-06-20
    • Setsuro FujiiHiroyuki KawamuraSeizo TairaRyoji MatsuiYojiro SakuraiToshiyuki Okutome
    • Setsuro FujiiHiroyuki KawamuraSeizo TairaRyoji MatsuiYojiro SakuraiToshiyuki Okutome
    • C07C205/56C07C279/18A61K31/24C07C101/447C07C129/12
    • C07C279/18C07C205/56Y10S514/822
    • Amino- or guanidino-phenylpropionic ester derivatives represented by the formula: ##STR1## wherein R is --NH.sub.2 or ##STR2## R.sup.1 is hydrogen or a lower alkyl group, and R.sup.2 is an unsubstituted or a lower-alkyl-, carboxyalkyl-, lower-alkoxy-, lower-alkoxycarbonyl- or halogen-substituted phenyl group or an unsubstituted or a halogen-substituted naphthyl group, and acid addition salts thereof are novel compounds exhibiting a specific enzyme-inhibitory activity to proteolytic enzymes and, therefore, they are useful as the therapeutic agent of diseases induced by abnormal activation of these enzymes. The above-mentioned compounds can be produced by subjecting a nitrocinnamic acid derivative represented by the formula: ##STR3## and a phenol derivative or a naphthol derivative represented by the formula:HO--R.sup.2to an esterification in the conventional manner to obtain a nitrocinnamic ester derivative, then reducing the latter compound to obtain an aminophenylpropionic ester derivative and, if desired, reacting it with cyanamide to obtain a guanidino-phenylpropionic ester derivative and, if desired, further converting the reaction product to an acid addition salt.
    • 由下式表示的氨基或胍基 - 苯基丙酸酯衍生物:其中R是-NH 2或R 1是氢或低级烷基,R 2是未取代的或低级烷基 - 羧基烷基 - 低级 - 烷氧基 - ,低级烷氧基羰基或卤素取代的苯基或未取代的或卤素取代的萘基,其酸加成盐是对蛋白水解酶具有特异性酶抑制活性的新化合物,因此它们是有用的 作为由这些酶的异常活化引起的疾病的治疗剂。 上述化合物可以通过将下式所示的硝基肉桂酸衍生物和由式HO-R2表示的酚衍生物或萘酚衍生物以常规方式进行酯化而制得,得到硝基肌氨酸酯 衍生物,然后还原后一种化合物以获得氨基苯基丙酸酯衍生物,并且如果需要,可与氰酰胺反应,得到胍基 - 苯基丙酸酯衍生物,如果需要,将反应产物进一步转化成酸加成盐。
    • 36. 发明授权
    • Rapid assaying method for guanase
    • guanase快速检测方法
    • US4550076A
    • 1985-10-29
    • US424182
    • 1982-09-27
    • Nobumoto ChikazawaToshiharu MuraokaSetsuro Fujii
    • Nobumoto ChikazawaToshiharu MuraokaSetsuro Fujii
    • C12Q1/26C12Q1/28C12Q1/34
    • C12Q1/28C12Q1/34G01N2333/978
    • The guanase activity in body fluids such as blood serum can be rapidly and accurately assayed by (I) decomposing guanine with the guanase in the specimen to xanthine and ammonia at pH 7-9, preferably at pH 8, (II) decomposing the xanthine formed by former step I with xanthine oxidase to uric acid and hydrogen peroxide, (III) reacting the reactant solution of the former step II with 3-methyl-2-benzothiazolinonehydrazone, an aniline derivative such as N,N-di-lower-alkylaniline and peroxidase, and finally measuring the optical absorption of the reactant solution of the step III at 570-600 nm. The all steps can be completed within 15 minutes. Therefore, this assay is adoptable for automatic assay of guanase on usual clinically available automatic analyzers.
    • 通过(I)将样品中的鸟嘌呤分解为黄嘌呤和氨,pH7-9,优选pH8,(II)分解形成的黄嘌呤的鸟嘌呤,可快速准确地测定体液如血清中的鸟苷酸活性 通过前一步骤I将黄嘌呤氧化酶与尿酸和过氧化氢反应,(III)使前一步骤II的反应物溶液与3-甲基-2-苯并噻唑酮腙,苯胺衍生物如N,N-二低级烷基苯胺和 过氧化物酶,最后在570-600nm测量步骤III的反应物溶液的光吸收。 所有步骤可在15分钟内完成。 因此,该测定法可用于通常临床可用的自动分析仪上的鸟苷酸的自动测定。